Home › Non-Small Cell Lung Cancer › Texas › Plano
Non-Small Cell Lung Cancer clinical trials in Plano, TX
4 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Plano (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RecruitingPhase 3
- Research Site, Plano
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Texas Oncology - DFW, Plano
- Texas Oncology - DFW, Plano
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Texas Oncology - DFW, Plano
- Texas Oncology - DFW, Plano
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #50, Plano
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX143 studies
- New York City, NY123 studies
- Arlington, VA111 studies
- Nashville, TN97 studies
- Los Angeles, CA92 studies
- Boston, MA87 studies
- St. Louis, MO68 studies
- Baltimore, MD60 studies
- San Antonio, TX60 studies
- Chicago, IL59 studies
- Columbus, OH57 studies
- Seattle, WA55 studies
Other studies in Plano
- Heart Failure13 studies
- Cardiovascular Disease10 studies
- Coronary Artery Disease9 studies
- Aortic Valve Stenosis5 studies
- Obesity4 studies
- Heart Diseases4 studies
- Depression4 studies
- Schizophrenia3 studies
- Tricuspid Valve Insufficiency3 studies
- Hypertrophic Cardiomyopathy3 studies
- Angina3 studies
- Aortic Dissection3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.